PRECISION BIOSCIENCES
Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.
PRECISION BIOSCIENCES
Industry:
Biotechnology Genetics Health Care Medical
Founded:
2006-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.precisionbiosciences.com
Total Employee:
101+
Status:
Active
Contact:
+1 919 314-5512
Email Addresses:
[email protected]
Total Funding:
265.15 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API WordPress Google Maps Font Awesome IPv6
Similar Organizations
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Precision BioSciences
Aquilo Capital Management
Aquilo Capital Management investment in Post-IPO Equity - Precision BioSciences
LYFE Capital
LYFE Capital investment in Post-IPO Equity - Precision BioSciences
Janus Henderson Investors
Janus Henderson Investors investment in Post-IPO Equity - Precision BioSciences
Aliment Capital
Aliment Capital investment in Debt Financing - Precision BioSciences
F-Prime Capital
F-Prime Capital investment in Series B - Precision BioSciences
Ditch Plains Capital Management LP
Ditch Plains Capital Management LP investment in Series B - Precision BioSciences
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Precision BioSciences
The Longevity Fund
The Longevity Fund investment in Series B - Precision BioSciences
Leerink Partners
Leerink Partners investment in Series B - Precision BioSciences
Key Employee Changes
Official Site Inspections
http://www.precisionbiosciences.com Semrush global rank: 3.52 M Semrush visits lastest month: 3.68 K
- Host name: 30.250.154.104.bc.googleusercontent.com
- IP address: 104.154.250.30
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Precision BioSciences"
Precision BioSciences - Wikipedia
Precision BioSciences' proprietary technology is the ARCUS platform and ARCUS nucleases. ARCUS nucleases are based on a naturally occurring genome editing enzyme, I-CreI, a homing endonuclease that evolved in the algae Chlamydomonas reinhardtii to make highly specific cuts and DNA insertions in cellular DNA. The nuclease is able to deactivate itself once gene edits are made, which minimizes potential off-targeting. An ARCUS nuclease is also much smaller in siz…See details»
Who We Are - Precision BioSciences
Before Thanksgiving break in 2004, as postdoctoral fellows at Duke University, Jeff Smith, Ph.D. and Derek Jantz, Ph.D. were excited about a new discovery – one that would lead to the …See details»
Precision BioScience - Overview, News & Similar companies
Precision BioScience contact info: Phone number: (919) 314-5512 Website: precisionbiosciences.com What does Precision BioScience do? Precision BioSciences is a …See details»
Precision BioSciences - Crunchbase Company Profile & Funding
Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the …See details»
Precision BioSciences, Inc. | LinkedIn
Precision BioSciences, Inc. | 20,556 followers on LinkedIn. Dedicated to Improving Life. | Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company …See details»
Precision BioSciences Corporate Presentation
In our other filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and the Investors page of our website under SEC Filings at investor.precisionbiosciences.com. …See details»
Board Company Guidelines - Precision BioSciences
Mar 6, 2023 PRECISION BIOSCIENCES, INC.. CORPORATE GOVERNANCE GUIDELINES. The Board of Directors (the “ Board”) of Precision BioSciences, Inc. (the “ Company”) has …See details»
Precision BioSciences Announces Senior Leadership Organizational ...
Sep 2, 2022 Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene edSee details»
Precision BioSciences Appoints Michael Amoroso Chief Executive …
Sep 27, 2021 DURHAM, N.C.--(BUSINESS WIRE)--Sep. 27, 2021-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company using its ARCUS genome editing …See details»
Precision BioSciences Appoints Juli Blanche as Chief …
May 23, 2022 New Senior Executive Brings 25 Years of Human Resources Leadership and Pharma Industry Experience. DURHAM, N.C.--(BUSINESS WIRE)--May 23, 2022-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical …See details»
Precision BioSciences - Craft
Oct 29, 2024 Precision BioSciences has 5 employees at their 1 location and $48.73 m in annual revenue in FY 2023. See insights on Precision BioSciences including office locations, …See details»
PRECISION BIOSCIENCES:
Www.sec.gov and the Investors page of our website under SEC Filings at investor.precisionbiosciences.com. All forward-looking statements speak only as of the date of …See details»
Precision BioSciences Employer Profile - North Carolina
Learn more about the pioneers leading the next genetic revolution at: www.precisionbiosciences.com. Benefits. 100% Company-Sponsored Health Benefits 8 …See details»
Precision BioSciences Announces Executive Leadership Change
DURHAM, N.C., Dec. 14, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL) a clinical stage biotechnology company dedicated to improving...See details»
Precision BioSciences Announces Change to its Board of Directors
Nov 10, 2022 - Raymond F. Schinazi, Ph.D., to Step Down from Board of Directors and Continue as a Member of the Company’s Scientific Advisory Board (SAB) DURHAM, N.C.- …See details»
How Does Precision BioSciences Work? – CBM
Dec 19, 2024 Website: precisionbiosciences.com Mission: To improve life through innovative genome editing technologies Through collaborations with leading research institutions and …See details»
Precision BioSciences Announces CEO Transition Plan
Apr 6, 2021 Begins Search for Next Chief Executive Officer. DURHAM, N.C., April 06, 2021 (GLOBE NEWSWIRE) -- Precision BioSciences Inc. (Nasdaq: DTIL), a clinical stage …See details»
Working at Precision BioSciences - Zippia
Mar 14, 2024 precisionbiosciences.com. Organization Type. Public. Social Media. Precision BioSciences is a biotechnology company dedicated to improving lives through its next …See details»
Our Team - Precision BioSciences
Our team includes pioneers in genome editing and leaders in cell and gene therapy who are committed to solving significant medical problems.See details»